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Introduction
Fatigue, with a prevalence of at least 65 % [1, 2], is one of the most 
common symptoms of multiple sclerosis (MS) and has far-reaching 
effects on the quality of life and employment, even statistically tak-
ing into account the degree of motor impairment [3]. Fatigue is a 
subjective sensation of lack of energy and exhaustion which can 
only be measured directly in the form of verbal reports. Due to its 
primarily subjective character, the concept of fatigue includes var-
ious aspects of human experience and behavior. Therefore, its 
measurement is mainly based on questionnaires and clinical inter-
views. It should be kept in mind that the structure of these 2 data 
collection methods depends on the internal model the researcher 
applies, which determines the content, number and direction of 
the questions posed to the patient with fatigue.
Despite the genuinely subjective sensation of fatigue, different 
methods are available to measure and diagnose it. These can be 
distinguished according to whether the pure state of fatigue is 
being measured or whether a change in feeling is being objectively or 
subjectively surveyed. The usual questionnaires gather data on 
the condition using subjective methodology, that is, responses to 
specific questions that categorize the current state [4]. They do not 
record the experienced change in fatigue in certain stressed or un-
stressed situations. Similarly, an attempt can be made to classify ob-
jective behavior. In the past, it was attempted to measure fatigue 
directly through the application of tests, comparing patients with 
and without fatigue while assuming different performance in the 
tests employed. On the other hand, focus was on the increase in loss 
of power and fatigue under continuous stress, with a measurement 
of either motor or cognitive effort The following provides an over-
view of the results obtained through these methods. The focus is, of 
course, on the questionnaires for the assessment of fatigue, since 
these continue to be the core of the fatigue diagnostics.
Criteria for the Diagnosis of “Fatigue”
There are currently no uniform criteria for the clinical diagnosis of 
MS-related fatigue, but rather various recommendations for the 
definition of fatigue and the possibility of measurement using ques-
tionnaires. Therefore Kluger et al., relying on an earlier review ar-
ticle on fatigue [4], suggested criteria for determining fatigue in 
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AbStr ACt
One of the most frequent symptoms in multiple sclerosis (MS) is fatigue. 
It has a major impact on quality of life as well as on professional activity. 
Even nowadays it is still unclear what constitutes an adequate assess-
ment of the perceived fatigue.
The following overview will discuss different possibilities to assess fa-
tigue with the help of questionnaires, clinical interviews or the objective 
measurement of cognitive performance. Furthermore, a structured 
guideline for the assessment of fatigue will be proposed. Clinical crite-
ria for MS related fatigue include the main symptoms, their everyday 
relevance, the possible causal relation with the cause of disease (the 
underlying MS), as well as an exclusion of other possible somatic or 
psychological reasons. It is recommended to use the “Würzburger Er-
schöpfungs-Inventar bei Multipler Sklerose (WEIMUS)” (English: 
Würzburg Fatigue Inventory for Multiple Sclerosis) and especially the 
“Fatigue Scale for Motor and Cognitive Functions” (FSMC), as these 
questionnaires distinguish between motor and cognitive fatigue and 
due to the larger number of research studies using the FSMC. Moreover, 
the presence of depression, quality of sleep and daytime sleepiness 
should be assessed. In addition, general cognitive performance as well 
as performance during monotonous stimulation (vigilance) should be 
assessed. This may be relevant for the evaluation of a patient’s capacity 
to work, and for determining prognosis, as there are indications for a 
relation to relapse frequency, a change from a clinically isolated syn-
drome (CIS) to an MS diagnosis with an increase of brain atrophy.
All in all, it can be said, that despite the growing convergence of diagnostic 
criteria, the available studies of the objective as well as the subjective assess-
ment of fatigue are still not sufficient and further research is needed.
E79
Sander C et al. Assessment of Fatigue in … Neurology International Open 2017; 1: E79–E85
Review
patients with Parkinson’s disease [5] which has been adapted to MS 
(▶table 1). Item A should provide differentiation from normal 
physiological tiredness (which would result in a value of 3), in that 
at least 4 of the possible 9 points should be confirmed for a diag-
nosis. Item B should include the impact on social and professional 
life. Item C should confirm the relationship with the primary dis-
ease, and Item D should rule out other possible causes of fatigue.
The definition of fatigue criteria in ▶table 1 appears to be very 
successful; direct application to clinical practice is also recommend-
ed in MS patients (including Item D, which is not always assumed 
with the necessary specificity).
Questionnaires for Diagnosing Fatigue
Diagnosis of clinically-relevant fatigue
In recent years the functionality, validity and reliability of available 
German-language questionnaires for the measurement of fatigue 
have been analyzed and summarized in various reviews [6–14]. We 
shall refer to these reviews in order to briefly recap their results 
(presented in ▶table 2) and shall then discuss additional aspects. 
Further English-language methods can be found in Khan, Amatya 
and Galea [13].
The functionality of questionnaires depends on their purpose. 
The focus is on 2 diametrically opposed issues. On the one hand, 
using questionnaires can be used to distinguish patients who show 
clinically-relevant fatigue from those who show no clinically-rele-
vant fatigue. Questionnaires devoted to this purpose should have 
appropriate cut-off values that allow such discrimination. They 
should take into account all relevant aspects of fatigue and, if pos-
sible, provide different related cut-off values. In our view, the WEI-
MUS, FSMC as well as the MFIS would be suitable (▶table 2). On 
the other hand, measurement of change is a focal point, that is, the 
extent to which change caused by an intervention affects an spe-
cific aspect of the experience of fatigue. In general such question-
naires are unidimensional and should have a high degree of relia-
bility so that even small test – retest deviations can be detected as 
interpretable changes. As multidimensional questionnaires, both 
the WEIMUS and FSMC meet these criteria (▶table 2).
With respect to construct validity, not all questionnaires fulfill 
the criterion of differentiated recognition of different aspects of fa-
tigue. Thus, the Fatigue Severity Scale, which is certainly the most 
frequently used fatigue scale, does not distinguish between motor 
and cognitive fatigue, whereas e. g., the MFIS, WEIMUS and the 
FSMC provide such a distinction and also offer differentiated cut-
off values. Furthermore, the MFIS questionnaire provides the di-
mension of socially-interactive fatigue. However, to date, there is 
no evidence of whether this dimension is truly an independent form 
of fatigue.
On the other hand, the difference between motor and cognitive 
fatigue is plausible based on outer appearances, and it has now also 
been shown that this aspect may have a prognostic significance. 
Our recent study [15] demonstrated that the indication of cogni-
tive fatigue at time t1 predicts the development of cerebral atro-
phy and subclinical demyelination in the area of the corpus callo-
sum as well as the relapse rate for the following 17 months. On the 
other hand, the presence of motor fatigue at time point t1 did not 
correlate with the rate of relapse or cerebral atrophy or subclinical 
demyelination in the region of the corpus callosum [15].
▶table 1  Criteria for the diagnosis of MS-related fatigue to based on criteria for determining fatigue in patients with Parkinson's disease according to 
Kluger et al. Parkinson's disease-related fatique: a case definition and recommendations for clinical research. Mov Dis 2016; 31: 625–631 (5). [rerif] 
[5].
Criteria for the diagnosis of MS-related fatigue
Patients must report significantly diminished energy levels or increased perceptions of effort that are disproportionate to attempted activities or 
general activity level. Symptoms must be present for most of the day every day or nearly every day during the previous month. In addition, patients 
must have 4 or more of the symptoms from section A as well as meet criteria in sections B, C, and D.
A. Symptoms
1. Symptoms may be induced by routine activities of daily living.
2. Symptoms may occur with little or no exertion.
3. Symptoms limit the type, intensity, or duration of activities performed by the patient.
4. Symptoms are not reliably relieved by rest or may require prolonged periods of rest.
5. Symptoms may be brought on by cognitive tasks or situations requiring sustained attention including social interactions.
6. Patients avoid rigorous activities because of fear of experiencing worsening of symptoms.
7. Mild to moderate exertion may induce a worsening of symptoms lasting hours to days.
8. Symptoms have a predictable diurnal pattern regardless of activities performed (eg., worsening in the afternoon).
9. Symptoms are unpredictable and may have a sudden onset.
b. Fatigue causes clinically-relevant stress in the patient or impairment of functional capacity in social, occupational or another important range 
of activities.
C. There is evidence from the history and physical examination suggesting fatigue is a consequence of multiple sclerosis.
D. Symptoms are not primarily a consequence of a comorbid psychiatric disturbance (e. g., depression), sleep impairment (e. g., obstructive 
sleep apnea) or other health issue (e. g., anemia, heart disease).
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The varying dimensionality of the questionnaires could also be 
a reason that the correlation between different questionnaires is 
usually moderate but not necessarily high. Flachenecker et al. 
showed, for example, that the correlation between MFIS and FSS is 
in the range of r = 0.56, which corresponds to a shared variance of 
only 31 %, which also means that substantial proportions of the var-
iance detected are differently elucidated [16]. According to our data 
based on 168 patients with MS who were interviewed in the con-
text of different research projects, FSS and FSMC total scores cor-
relate with an r of 0.76, which corresponds to a shared variance of 
approximately 60 %.
Overall, however, it must be noted that comparative studies 
among the questionnaires and the external validity of the fatigue 
questionnaires are scarce, and even more rarely those which are 
concerned with the question of whether the grading of mild, mod-
erate and severe fatigue is comparable and meaningful. However, 
the establishment of clinically-relevant fatigue would require pre-
cisely such external validation.
In the past, we carried out a series of studies that included, among 
other things, occupational activity and a whole series of question-
naires on fatigue, depression, sleep quality and daytime tiredness. 
We relied on the FSS and FSMC for the assessment of fatigue. The 
FSMC is the only fatigue questionnaire listed in ▶table 2 providing 
cut-off scores for grading the severity of fatigue. Breaking down 
our data of the 168 MS patients (see above) by the status of occu-
pational activity: employed full-time (n = 36), working half-time 
(n = 35), not employed (generally women with children) (n = 21) 
and retired (n = 76) only the total value of the FSMC results in a sig-
nificant difference among these groups, after statistical control. 
Retired people indicate significantly higher fatigue values than 
those in the employed groups. On the other hand, the results for 
the other questionnaires (as well as the FSS) are far from showing 
significant differences.
A corresponding validation of the fatigue scales would also be 
useful with regard to the clinical relevance of the proposed cut-off 
values, but the authors are unaware of such studies. In our data-
base according to the FSS, 44.4% of MS patients with no fatigue 
(FSS < 4) were employed fulltime and 38.8% had at least moderate 
fatigue (FSS > 5). Among the retired, the ratio was 27.6 to 44.7%. 
For the FSMC total, the ratio for full-time employees was 16.7 to 
44.4%, and for pensioners 3.9–80.3 %. According to the FSMC, 92 % 
of the pensioners suffer at least moderate fatigue (44.7 % accord-
ing to the FMS). These numbers show that the external validity of 
the severity classification of the FSMC significantly exceeds that of 
the FSS. However, 44.4 % of full-time workers rate their fatigue as 
severe using the FSMC, thus documenting that the mere extent of 
reported fatigue should not be sufficient for deciding social-med-
ical issues.
Fortunately, however, the reliability of most of the fatigue ques-
tionnaires in the reviews we have mentioned is considered to be 
adequate, as was shown by Flachenecker’s study (▶table 2) [6].
Regarding the practical aspect of the different amounts of time 
required to complete the questionnaires, in our view they all fall 
within a reasonably tolerable range (approx. 5–10 min)
Assessment of clinically-relevant changes in  
fatigue experience
Most fatigue questionnaires are not designed to assess short-term 
changes in the experience of fatigue (e. g., immediately after a re-
laxation exercise or 1–2 h after administration of L-dopa) because 
they presuppose internal averaging of the experience over a peri-
od of time (refer to the relevant user instructions). Because of this, 
researchers usually rely on so-called visual analog scales. However, 
this change to another mode of representation is less useful, since 
different studies show that such analog scales correlate weakly to 
moderately to more comprehensive fatigue scales.
▶tab. 2 Overview of the German-language fatigue questionnaires.
Name Number 
of items
Forms of fatigue Construct validity retest 
reliability
Scope of application
FSS [9] 9 General fatigue Excellent [7, 10] Acceptable (more 
than 6 months) 
[7, 6]
– Screening for fatigue
–  Particularly for measuring 
motor fatigue [7]
– Follow-up [7]
WEIMUS [11] 17 Cognitive and motor 
fatigue
Excellent [12] Excellent (more 
than 14 days) 
[11]
– Screening for fatigue
FSMC [13] 20 Cognitive and motor 
fatigue
Excellent [13] Excellent (more 
than 4 weeks) 
[13]
– Screening for fatigue
–  Classification of the severity 
of fatigue [13]
MFIS [14] 21 Cognitive, motor and 
psychosocial fatigue
High (particularly with 
respect to motor aspects 
of fatigue) [7]
Acceptable (more 
than 6 months) 
[6, 7]
– Influence of fatigue
–  In particular measurement of 
fatigue on motor function [7]
– Follow-up [7]
FSS: Fatigue Severity Scale, WEIMUS: Würzburger Erschöpfungs-Inventar bei Multipler Sklerose, (Würzburger Fatigue Inventory for Multiple Sclerosis), 
FSMC: Fatigue Scale for Motor and Cognitive Functions MFIS: Modified Fatigue Impact Scale
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Conventional fatigue scales can also be used for change meas-
urement if assessment of a longer-term intervention with a gap of 
at least 2 weeks is needed. However, little or nothing is known 
about their sensitivity and specificity in the detection of changes 
in fatigue experience. Based on the literature, Learmonth et al. con-
cluded that the FSS is suitable for measuring changes in the fatigue 
experience, although no corresponding information is available for 
most of the other scales [7]. In our non-interventional follow-up 
study [15], in which MS patients as well as healthy controls were 
examined at 2 time points at an interval of 17 months with respect 
to existing fatigue symptoms as well as changes in imaging, a rel-
atively high correlation was found for the subscales of the FSMC, 
whereas the FSS did not demonstrate high time stability (▶Fig. 1). 
Likewise, the study by Johansson et al. showed a marked fluctua-
tion of fatigue experienced over time when assessed with the FSS 
[17]. Given the absence of an external criterion and the lack of tar-
geted observation studies, it is impossible to indicate whether this 
variation in FSS values is an expression of higher change sensitivity 
or inaccurate measurement. In any case, our results show that a 
change in fatigue measured with the FSMC would have a high sig-
nificance, as the values in this questionnaire obviously fluctuate lit-
tle over time.
A study by Learmonth et al. to determine the psychometric 
properties of FSS and MFIS over 6 months also measured clinical-
ly-relevant change. For the FSS, 1.9 points (38 % of the total score) 
indicate a clinically-relevant change. For the MFIS, 20.2 points are 
necessary to achieve a clinically-relevant change in the score [7].
Svenningsson, Falk, Celius, et al. [18] investigated the effect of 
natalizumab on the perception of fatigue. The FSMC was used to 
assess subjectively perceived fatigue, and a change of 9 points in 
the total score was considered clinically-relevant.
Lacking further studies, the definition of clinically-relevant 
changes in fatigue questionnaires is largely subjective. If classifica-
tion is based on the degree of severity, the score between two de-
grees of severity could be considered as clinically relevant, prag-
matically. In the case of the FSMC this would be 6 points per scale 
(that is, for the cognitive and motor scale). If a change of ½ SD 
would be considered clinically relevant for the FSMC, then accord-
ing to our data, this would represent a change of 4 points. This con-
curs with the classification of Svenningsson, Falk, Celcius et al., since 
the calculated 4 points per subscale necessary for a clinical change 
coincide almost with the 9 points necessary for the overall scale 
[18].
For the FSS a change by one average point would be relevant 
(i. e., between light fatigue, FFS value of 4, and moderate fatigue 
with an FFS value of 5).
Measurement of the responsive 
 experience of fatigue
Distinguishing between patients with and without fatigue is an 
issue in everyday clinical practice. A measure of the subjective in-
crease in fatigue under standardized conditions would be of great 
importance for the assessment of socio-medical questions as well 
as for the relationship between fatigue and tiredness. In principle 
this issue would relate to psychophysics. Which standardized 
change in the objective burden or relief of MS patients corresponds 
to what difference in fatigue?
In fact, there have been very few attempts at such a psychophys-
ical measurement of fatigue; for the most part fatigue and the man-
ifestation of fatigue at time of onset are purely additive. Thus Moller 
et al. [19] demonstrated that with subjectively the same motor ef-
fort, healthy controls and MS patients respond with the same de-
gree of additional fatigue over time. The induced fatigue after 
motor stress was as high in non-patients as in MS patients and was 
therefore additive to the fatigue at the time of onset. Similar results 
were also obtained by Lehmann et al. in a cross-over experiment in 
which MS patients and healthy controls spent over 10 min on a 
working memory task, then watched a stimulating or relaxing video 
sequence before resuming the working memory activity [20]. The 
group which was first allowed to relax, then received stimulation, 
while the other group was allowed to relax. The result showed that 
the extent of induced fatigue was the same in all groups (the MS 
group was divided into those with and without fatigue) and also 
did not depend on the interim conditions. In the past we system-
atically analyzed the existing literature on this topic [21]. Overall, 
there is so far no significant evidence that MS patients and healthy    D )DWLJXH6HYHULW\6FDOHW )DWLJXH6HYHULW\6FDOHW)663HDUVRQ·VU     E )DWLJXH6FDOHIRU0RWRU)XQFWLRQ DQG&RJQLWLRQW )DWLJXH6FDOHIRU0RWRU)XQFWLRQDQG&RJQLWLRQW)60&WRWDO9DOXH3HDUVRQ·VU
▶Fig. 1 Correlation of fatigue values of the Fatigue Severity Scale (FSS) a as well as the total value of the Fatigue Scale for Motor and Cognitive 
Functions (FSMC) b at the start of the study (t1) as well as after 17 months (t2) [15].
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controls differ in the increase in fatigue experience when they are 
equally burdened. Those MS patients starting at a higher initial level 
do not differ in relative increase.
Measurement of Fatigue using  
Neuropsychological Test Procedures
At its core, fatigue is a vegetative-cognitive syndrome [4], corre-
spondingly it is presumed that fatigue is best measured using neu-
ropsychological tests, thus enabling identification of chronic traits 
[4]. However, as 2 reviews have shown, measuring fatigue using 
neuropsychological testing is highly complex [21, 22]. To do this, 
2 strategies must be distinguished. On the one hand, cognitive dif-
ferences between patients with and without fatigue must be 
demonstrated. In reality, this attempt has failed for almost all test 
procedures. The presence of fatigue experience does not mean that 
these patients have major problems in the area of memory, speech 
functions, visuo-constructive functions or executive functions in 
the narrower sense [21, 23, 24]. Even if many of these studies suf-
fer from methodological problems, such as consisting of clinical 
tests constructed for totally different purposes applied on MS-pa-
tients with Fatigue, they demonstrate the same basic trend, not 
showing a relation between subjective fatigue and cognitive per-
formance.  Inspired by animal experiments, theoretically motivat-
ed replication would be desirable, e. g., between contextually in-
fluenced memory performance and those without the requirement 
for consideration of context-related information [25]. Neverthe-
less, until such studies have been established, it is not possible to 
distinguish MS patients with fatigue from those who do not suffer 
from fatigue by using test batteries according to current knowl-
edge.
On the other hand, tests, which focus on sustained attention, i.e. 
holding attention over a period of time, or vigilance, i.e. maintining 
attention in the face of monotony, seem to be an exception in this 
context. Testing procedures to investigate attention could include 
the Alertness and Vigilance Test of the TAP as well as the Symbol Digit 
Modalities Test. Especially regarding the Alertness Test there are a 
number of studies suggesting a valid variable selectivity among MS 
patient cohorts with respect to the “fatigue experience” paradigm 
[26–31]. Based on this group of studies, as well as those on the in-
fluence of cognitive stress and time of day on performance shown in 
the Alertness Test, but not in the testing of selective attention [32] 
this test is already in use in some clinics as a procedure for testing the 
capability to work [31].
However, methodological problems limit the value of the re-
sults. The correlative relationship between fatigue experience and 
extent of neurological impairment has been repeatedly replicated. 
In tests that vary very finely in time, this correlation can cause pa-
tients with fatigue to perform worse because their fine motor per-
formance is often lower. This applies to the Alertness Test as well 
as the Symbol Digit Modalities Test, in which symbols or numbers 
have to be written in small boxes, and the number of the correct 
boxes within a time span is the critical variable. A further problem 
occurs if patients with cognitive fatigue are compared with healthy 
controls only and a comparison with MS patients without cognitive 
fatigue is missing (see Neumann, Sterr, Claros-Salinas et al. [26] as 
well as Claros-Salinas, Dittmer, Neumann et al. [29]). Thereby it can 
not be assured that the decline of the reaction time can be attrib-
uted to the existing cognitive fatigue. It cannot be ruled out that 
the slowing of reaction times is related to the disease multiple scle-
rosis itself.
Moreover, in some of these studies the degree of depression was 
not always subject to adequate statistical controls [28]. Claros-Sali-
nas, Dittmer, Neumann et al. [29] as well as Neumann, Sterr, 
Claros-Salinas et al. [26] excluded patients with moderate to severe 
depression, but their analysis did not take into account the BDI-II 
value, so that the effect of mild depression cannot be fully ruled out 
(see [26, 29]). In addition, the correlation with the fatigue experi-
ence did not relate to the characteristic value of phasic alertness, 
but to the reaction time, in which the fatigue experience should be 
compensated by a previous acoustic cue [26].
The studies by Weinges-Evers, Brandt, Bock et al. [27] are an ex-
ception. They found a correlation between performance in the TAP 
Alertness Test and the results of the FSS. They performed a statis-
tical correction for age, EDSS, education and BDI values [27].
Studies such as these are an indication that the TAP Alertness 
Test offers an option for the measurement of cognitive fatigue, but 
further validation is needed.
These remarks concern only the direct application of relatively 
short tests for the objectification of fatigue as well as test batteries 
which provide frequent changes between short tests. Another 
strategy in the measurement of fatigue analyzes the effect on the 
test process, the so-called time-on task effect, and this could 
 actually represent a central variable [33]. Fot the PASAT several re-
search groups have shown (although not always reproducible) that 
the MS patients with fatigue show a stronger performance decline 
compared to non-fatigue groups at the end of the test [34]. For the 
group of vigilance tests it could also be demonstrated (with a nota-
bly higher replication rate) that MS patients with fatigue show a 
slowed response time from 20 min onwards and, in some cases, an 
increased rate of disregard of critical stimuli. Prior studies on alert-
ness testing indicated that their sensitivity is high if testing is repeat-
ed after a phase of intensive load. In this respect, the duration of a 
load with a more monotonous character seems to be a decisive fac-
tor in determining whether fatigue is reflected in the measurement 
of cognitive performance. This could be interpreted as increased 
inner distractibility resulting from the fatigue experience, which is 
particularly evident when the environmental stimuli lose their at-
tractiveness through monotony.
Summary
About 30 years after Krupp et al. designed the Fatigue Severity 
Scale [9], adequate measurement of fatigue remains a central prob-
lem for the clinical practice. Similar to other symptoms (such as de-
pression) which recur due to purely internal sensations, diagnosis 
remains based on clinical plausibility assumptions.
This short survey article shows that especially when it comes 
to social-medical considerations, the mere use of questionnaires 
is insufficient. Clinical judgment based each entry in ▶table 1 is 
recommended for diagnosis. This presumes targeted questioning 
of the patient. Utilizing questionnaires supports clinical judgment. 
Using the FFS exclusively appears insufficient to get an impression 
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of the experience of fatigue. Due to more extensive evaluation, 
the WEIMUS is recommended as well as the FSMC for the German- 
speaking region. Both differentiate between motor and cognitive 
fatigue. In addition, the assessment of depression, sleep quality 
and daytime sleepiness is supported by questionnaires such as the 
Beck Depression Inventory [35] (excluding the somatic items), the 
Hospital Anxiety and Depression Scale (HADS) [36] the Pittsburgh 
Sleep Quality Index (PSQI) [37] and the Epworth Sleepiness Scale 
(ESS) [38]. In terms of research, external validation of the degrees 
of severity of the fatigue scales, for example, decisions relating to 
shortening working hours, represents a simple to accomplish –but 
urgently necessary – task.
In addition to surveying MS patients, objectification of the fa-
tigue experience should be attempted through psychological test-
ing. This is the case because the experience of fatigue as such is not 
equivalent to the inability to work, which must be subject to a sep-
arate consideration; conversely, cognitive deficits can also be pres-
ent without the presence of fatigue. In the context of neuropsycho-
logical research, in addition to the determination of cognitive per-
formance, the assessment of performance under monotony is a 
focal point. Vigilance tests requiring maintenance of continuous 
attention should especially be able to identify patients suffering 
from fatigue. If this is the case, then, from a social-medical point of 
view, this should be a reason to consider whether full-time employ-
ment is still possible or if a complete withdrawal from working life 
should be considered.
In the area of the objective assessment of motor fatigue, the 
kinematic gait analysis, in which the gait pattern before and after 
a motor task is compared [39], is used to measure the severity or 
the presence of motor fatigue. So far, no correlation with subjec-
tive motor fatigue has been found, so further validating studies are 
needed.
Objectification of the fatigue experience plays a role beyond so-
cial-medical decisions. Recent studies show that the experience of 
fatigue could also play a prognostic role in whether MS patients will 
experience a relapse in the coming months [15], will change from 
CIS status toward a diagnosis of MS [40] or suffer increased cere-
bral atrophy [15, 41, 42]. Furthermore, there are very limited indi-
cations that the choice of immunomodulatory medication may 
have an effect on the fatigue experience [43]. Therefore, addition-
al studies on the improved detection of fatigue are still urgently re-
quired in 2017.
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